Salman Hussain is a panelist during the summit where he is discussing patient-focused drug development in alopecia areata.
For more information on this event, click here.
MFN is rewriting the launch planning playbook: Commercial and market access strategies must integrate to succeed
MFN-related uncertainty is reshaping pharmaceutical launch planning by making pricing, sequencing, and forecasting decisions more interconnected and...